Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Hot topicsChairs: F. Martinez (New York, United States of America), E. Wouters (Maastricht, Netherlands)
Aims: To present and discuss the data of three recent randomised controlled trials that explored the ability of intensified inhaled corticosteroid (ICS) therapy to prevent exacerbations in patients with asthma and COPD who present with acute poor symptom control or upper respiratory tract infections (URTIs).